Does anyone have a policy that treats overrides differently in the ED? They often override meds that aren't technically on our list because they just need to get them quickly and are at the machine at the time (like antibiotics for example). I totally understand why they would do that, but at the same time it's not emergent to the patient's care.

I'd love to hear any success stories re: improving Alaris Guardrails compliance in oncology areas. Thanks in advance, and I can be contacted privately.

There was another thread from a few years ago about how you document for a patient alpha gal. However, we are struggling with how to operationalize this. For those with a program set up, can you answer:

Hi everyone,
Does anyone here run their Medication event committee meeting to adjudicate events that come through their reporting system? I'm looking to see if anyone has a format that they would be willing to share.
Thanks,
Jewell

Is there a regulatory recommendation for how long a medication drawer on a cart should remain open?

Med Reconciliation at all transitions of care commonly lead to error. While we do a good job at ensuring that we have some sort of reconciliation at the admission and discharge points, it is the transitions between levels of care that can be problematic at times. Our health-system is about to undertake a look into our hurdles and design an initiative to close our gaps in this area.

Please take the survey below so to help look across our health-systems to identify common issues and strategies others have taken. I will share the de-identified results with any that would like.

We are trying to better organize our insulin fridge with improved storage bins and signage. Would anyone be willing to share a picture of their insulin fridge storage within your central pharmacy?

Hello,

Two questions related to reactions to carboplatin.

1. Are there any facilities or sites noticing an increase in reports of adverse drug reactions between brands of carboplatin? With the current carboplatin shortage, there is a perception with some of our infusion centers that the Teva product may be resulting in an increase in ADRs for patients.

Hi everyone,

I am trying to gain a better understanding of how different locations approach their dispensing process for IVIG (vials vs pooling).

This forms poll should take ~ 1 minute to complete and I will circle back with the results in when it closes on June 1st.

I appreciate any additional feedback you feel comfortable sharing around decision making to pursue one method or the other.

https://forms.office.com/r/5rfPdSSG9N

Thanks!
Brent Dammeier

Does anyone know of a best practice guideline for a timeline requirement for clinicians to return unused / unopened medications to the automated dispensing machine (Pyxis, Omnicell, etc.) after they've taken the med out of the machine for a patient and then not used them (ie. patient refused, etc.)?

Or, if you don't know of a published guideline, what timeline does your facility require?

Note: I'm not talking about wasting medication, but rather returning unused / unopened medication.

Thanks -
Chad